Home > Analytics > NGL FINECHEM

NGL FINECHEM
Intrinsic Value | Fundamental Analysis

BOM : 524774     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Dec 02,2022
Price(EOD): ₹ 1,660.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,029.29 Cr
Value of ₹ 1 Lac invested in NGL FINECHEM
on Dec 04,2017 (price: ₹ 395.55)

₹ 1 L

₹ 4.20 L

1W : -5.2% 1M : 4.5% 1Y : -34.6%
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
NGL FINECHEM -5.2% 4.5% -34.6%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -1.1% 38.8%
DIVIS LABORATORIES 0.2% -10.6% -30.7%
DR REDDYS LABORATORIES 2.5% -1% -5.8%
CIPLA 1% -4% 15.8%
GLAND PHARMA -1.3% -8.4% -51.1%
PIRAMAL ENTERPRISES 4.8% 2.6% -64.3%
CADILA HEALTHCARE 4.1% -4.8% -11.6%
TORRENT PHARMACEUTICALS -0.9% -4.3% 7.9%

FUNDAMENTAL ANALYSIS OF NGL FINECHEM

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF NGL FINECHEM

 
Valuation Score
[As on : Dec 02,2022 ]

Ratio Consolidated
P/E
P/B
P/S
46.62
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 22.00 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

5.05
P/B Calculated based on Book Value of Rs 203.22 Cr
[Latest Year - Mar2022 - Consolidated Results ]

3.45
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 297.53 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF NGL FINECHEM

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
1359%
609%
638%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF NGL FINECHEM



NGL FINECHEM vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF NGL FINECHEM

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.15
0.11
0.28
0.18
0.15
0.11
0.29
0.18
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF NGL FINECHEM

Pledged Promoter Shares
0 %
As on : Sep2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF NGL FINECHEM

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
4.81%
508.25%
1054.06%
799.42%
-13.59%
-46.7%
-67%
-66.45%
QtrlyTrend
0
Latest Qtr: Sep2022
Quarterly Result Analysis →


NGL FINECHEM related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 2.6% 3.1% 7.8%
S&P BSE SMALL CAP 2.4% 3.5% 8.6%
S&P BSE ALLCAP 1.6% 2.7% 9.4%
S&P BSE HEALTHCARE 1.1% -1.6% -6.1%
No NSE index found

You may also like the below Video Courses


FAQ about NGL FINECHEM


Is NGL FINECHEM good for long term investment?

As on Dec 02,2022, the Fundamentals of NGL FINECHEM look Poor and hence it may not be good for long term investment ! See Financial Performance of NGL FINECHEM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NGL FINECHEM UnderValued or OverValued?

As on Dec 02,2022, NGL FINECHEM is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NGL FINECHEM ?

As on Dec 02,2022, the Intrinsic Value of NGL FINECHEM is Rs. 224.93 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 113.80
Fair Value [Median EV / Sales Model] : Rs. 234.19
Fair Value [Median Price / Sales Model] : Rs. 224.93
Estimated Median Fair Value of NGL FINECHEM : Rs. 224.93

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is NGL FINECHEM trading at a Premium or Discount?

As on Dec 02,2022, NGL FINECHEM is trading at a Premium of 638% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].